FDA Resources

The Biologics Price Competition and Innovation Act (BPCIA) was enacted in 2010 and granted the U.S. Food and Drug Administration (FDA) authority to create an abbreviated approval pathway for biosimilars. The FDA has several resources and educational materials for patients and prescribers on biosimilars, including the below:

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below: